RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B‐CELL LYMPHOMAS. (12th June 2019) - Jagadeesh, D.; Horwitz, S.; Bartlett, N.L.; Advani, R.; Jacobsen, E.; Duvic, M.; Gautman, A.; Rao, S.; Onsum, M.; Fanale, M.; Kim, Y.